BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Aug 28, 2026; 32(32): 119375
Published online Aug 28, 2026. doi: 10.3748/wjg.v32.i32.119375
Table 2 Pathological data, n (%)/median (interquartile range)
Variable
TOS (n = 122)
LHS (n = 144)
P value
Tumor site< 0.001
Right colon cancer73 (59.8)14 (9.7)
Left colon cancer22 (18.0)47 (32.6)
Rectal cancer27 (10.2)83 (57.6)
Maximum tumor size, cm
Primary lesion4.00 (3.00, 6.00)3.50 (2.50, 5.00)0.003
Liver metastases2.98 (1.57, 3.50)2.98 (1.80, 3.00)0.843
Differentiation of the primary lesion0.677
Poor differentiation28 (23.0)30 (20.8)
Medium and high differentiation94 (77.0)114 (79.2)
Number of lymph nodes16.00 (13.00, 19.00)14.00 (11.00, 17.00)0.001
Liver metastases number0.936
< 3113 (92.6)133 (92.4)
> 39 (7.4)11 (7.6)
pT stage0.810
0-210 (8.2)13 (9.0)
3-4112 (91.8)131 (91.0)
pN stage0.736
045 (36.9)47 (32.6)
154 (44.3)70 (48.6)
223 (18.9)27 (18.8)
KRAS gene0.426
Wild-type73 (59.8)93 (64.6)
Mutant-type49 (49.0)51 (35.4)
BRAF gene0.062
Wild-type117 (95.9)143 (99.3)
Mutant-type5 (3.4)1 (0.7)


Write to the Help Desk